Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma

OBJECTIVE: Calcitonin (Ct)-negative medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor. This study aimed to clarify its incidence, clinicopathologic characteristics, management, and treatment outcome. METHODS: We retrospectively analyzed data of patients with primary MTC. Patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Wenliang, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727137/
https://www.ncbi.nlm.nih.gov/pubmed/36506082
http://dx.doi.org/10.3389/fendo.2022.1025629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727137/
https://www.ncbi.nlm.nih.gov/pubmed/36506082
http://dx.doi.org/10.3389/fendo.2022.1025629

Ejemplares similares